BR9806303A - Sistema de distrituição de droga termoformado, e, unidade de dosagem - Google Patents

Sistema de distrituição de droga termoformado, e, unidade de dosagem

Info

Publication number
BR9806303A
BR9806303A BR9806303-0A BR9806303A BR9806303A BR 9806303 A BR9806303 A BR 9806303A BR 9806303 A BR9806303 A BR 9806303A BR 9806303 A BR9806303 A BR 9806303A
Authority
BR
Brazil
Prior art keywords
delivery system
thermoformed
drug delivery
dosage unit
drug
Prior art date
Application number
BR9806303-0A
Other languages
English (en)
Inventor
Steven E Frisbee
Deirdre M Barrow
Joseph Cascone
Barry D Mccarthy
Bernard M Kiernan
Hanan S Anwar
Beuford A Bogue
Claude Bayard
Abhijit Barnerjee
Original Assignee
Fuisz Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/946,070 external-priority patent/US6013280A/en
Application filed by Fuisz Technologies Ltd filed Critical Fuisz Technologies Ltd
Publication of BR9806303A publication Critical patent/BR9806303A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"SISTEMA DE DISTRIBUIçãO DE DROGA TERMOFORMADO, E, UNIDADE DE DOSAGEM". Um sistema de distribuição de droga processado via técnicas de transformação, apresentando propriedades de rápida liberação de agente ativo que são úteis nas formas de dosagem farmacêuticas. O sistema de distribuição pode ser utilizado como partículas que contêm agentes ativos e agentes de solubilização e que estão contidos em uma forma de dosagem.
BR9806303-0A 1997-10-07 1998-09-28 Sistema de distrituição de droga termoformado, e, unidade de dosagem BR9806303A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/946,070 US6013280A (en) 1997-10-07 1997-10-07 Immediate release dosage forms containing microspheres
US12916498A 1998-08-05 1998-08-05
PCT/US1998/020266 WO1999017744A1 (en) 1997-10-07 1998-09-28 Immediate release drug delivery forms

Publications (1)

Publication Number Publication Date
BR9806303A true BR9806303A (pt) 2000-03-14

Family

ID=26827301

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9806303-0A BR9806303A (pt) 1997-10-07 1998-09-28 Sistema de distrituição de droga termoformado, e, unidade de dosagem

Country Status (7)

Country Link
EP (1) EP0966269A1 (pt)
JP (1) JP2000507991A (pt)
KR (1) KR20000069356A (pt)
AU (1) AU9587198A (pt)
BR (1) BR9806303A (pt)
CA (1) CA2273272C (pt)
WO (1) WO1999017744A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992018106A1 (fr) * 1991-04-16 1992-10-29 Nippon Shinyaku Co., Ltd. Procede de production d'une dispersion solide
CA2348452A1 (en) * 1998-10-27 2000-05-04 Biovail Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
IE981008A1 (en) * 1998-12-02 2000-06-14 Fuisz Internat Ltd Microparticles Containing Water Insoluble Active Agents
CN1402629A (zh) 1999-12-23 2003-03-12 辉瑞产品公司 提供提高的药物浓度的药物组合物
US8980870B2 (en) * 2002-09-24 2015-03-17 Boehringer Ingelheim International Gmbh Solid telmisartan pharmaceutical formulations
US9149433B2 (en) * 2004-11-30 2015-10-06 Basf Corporation Method for formation of micro-prilled polymers
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1388786A (en) * 1972-04-03 1975-03-26 Scherer Corp R P Integral solid gel-lattice dosage form of high-moisture content
DE3927113C2 (de) * 1989-08-17 1993-11-25 Dolorgiet Gmbh & Co Kg Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung
CA2095776C (en) * 1992-05-12 2007-07-10 Richard C. Fuisz Rapidly dispersable compositions containing polydextrose
US5281420A (en) * 1992-05-19 1994-01-25 The Procter & Gamble Company Solid dispersion compositions of tebufelone
DE69309056T2 (de) * 1992-06-10 1997-09-18 Nanosystems L.L.C., Collegeville, Pa. Oberflaechenmodifizierte nsaid nanopartikeln
US5683720A (en) * 1994-10-28 1997-11-04 Fuisz Technologies Ltd. Liquiflash particles and method of making same
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs
CA2231050A1 (en) * 1995-09-07 1997-03-13 Biovail International Ltd. System for rendering substantially non-dissoluble bio-affecting agents bio-available

Also Published As

Publication number Publication date
WO1999017744A1 (en) 1999-04-15
CA2273272C (en) 2004-09-21
EP0966269A1 (en) 1999-12-29
KR20000069356A (ko) 2000-11-25
AU9587198A (en) 1999-04-27
CA2273272A1 (en) 1999-04-15
JP2000507991A (ja) 2000-06-27

Similar Documents

Publication Publication Date Title
AR030253A1 (es) Sistemas de suministro de drogas autoemulsionantes para drogas lipofilicas extremadamente insolubles en agua, una formulacion y el uso de una composicion para la fabricacion de un medicamento
SE0003449D0 (sv) Anticancer compositions
ATE509616T1 (de) Topische pharmazeutische und/oder cosmetische dosierungssysteme
DE69520492D1 (de) Flüssige arzneizubereitungen enthaltend schilddrüsenhormone
ES2126536B1 (es) "preparado farmaceutico para administracion intranasal y procedimientopara su produccion".
FI973419A0 (fi) Epäorgaanisten aerogeelien käyttö lääkkeiden valmistuksessa
ATE321532T1 (de) Pharmazeutische zubereitungen und verfahren zu deren lokalen verabreichung
ATE251449T1 (de) Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
PT1077680E (pt) Metodo de fabrico de uma forma de dosagem de agente activo com bandas de libertacao prolongada
BR0007974A (pt) Usos de um agente farmacologicamente ativo, deum constructo de gene e de um antìgeno, métodospara produzir uma composição farmacêutica em póe para administrar uma droga a um indivìduo emnecessidade dela, composição farmacêutica, formade dosagem unitária, e, artigo de manufatura parasuprimento transdérmico ou transmucoso de umagente farmacologicamente ativo a um indivìduo
EP1015008A4 (en) COMPOUNDS AND COMPOSITIONS FOR DELIVERY OF ACTIVE AGENTS
SI1051174T1 (sl) Gastroprotektirane omeprazolne mikrogranule, postopek za pridobivanje le-teh in farmacevtski pripravki
ATE275393T1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
ATE220290T1 (de) Wirkstoffhaltige aromatische copolyester
ES2166988T3 (es) Terapia de administracion uniforme de farmacos.
ATE311904T1 (de) Halbfester verabreichungsträger und arzneimittel
BR9806303A (pt) Sistema de distrituição de droga termoformado, e, unidade de dosagem
AR008886A1 (es) Uso de un inhibidor h+,k+-atpasa en la fabricacion de un medicamento para el tratamiento de polipos nasales, del sindrome de widal, uso de dicho inhibidor y un glucocorticoide para la fabricacion de una formulacion farmaceutica y formulacion farmaceutica para administracion simultanea
BRPI0414305A (pt) sistema de liberação de drogas por via oral
ES2172171T3 (es) Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles.
DK0871467T3 (da) Ny formulering til afgivelse af peptid
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
PT1144420E (pt) Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao
ES2193562T3 (es) Dispositivo de dosificacion.
NO20004816L (no) Ny farmasøytisk formulering

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]